9Grieco A, forgione A, Giorgi A. Propafenone- related cholestatic hepatitis in an elderly patient. Ital Heart J, 2002,3:431 -434.
10Sharma SK, Balamurugan A, Saha PK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med,2002,166:916 - 919.
2Andrade R J, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period [J]. Gastroenterology, 2005, 129(5):512-521.
3Bliven EE, Podewils LJ. The role of chronic hepatitis in isoniazid hepalotoxicity during treatment for latent tuberculosis infection [J]. Int J Tuberc Lung Dis, 2009,13(9):1054-1060.
